Excelsior

Quick facts

Phase 2 pipeline

• EX039
  EX039's mechanism of action is currently under investigation and not fully characterized.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Excelsior portfolio CI brief
• Excelsior pipeline updates RSS